Finance Biggo

Published September 14, 2026 · Updated September 15, 2026

Definium Therapeutics Jumps 20% After Third Phase 3 Win for LSD -Based Anxiety Drug

Read the full story at Finance Biggo

Definium Therapeutics (DFTX) shares surged roughly 20% in Monday's premarket session after the biotech reported that its LSD -derived drug candidate.